| Target Professions: | DO, MD, Nurse, Nurse Practitioner, Physician Associate/Assistant |
| Target Specialties: | Orthopedic Medicine/Sports Medicine |
| Credits Available: | 4.75 hours of AMA PRA Category 1 Credit™ |
Patients who are obese or overweight are more likely to require joint replacement surgery than their normal weight peers; however, higher BMIs also substantially increase the risks of orthopedic surgery. This increased risk often leads to orthopedic surgeons requiring that their patients lose weight and obtain a BMI of <40 kg/m2 before proceeding with surgery. In previous years, bariatric surgery may have been the only feasible option for these patients, but now anti-obesity medications, like GLP-1 receptor agonists, are a valid alternative and may be more palatable for patients. Through this program, orthopedic surgeons will gain a deeper understanding of how they can appropriately select patients who may benefit from GLP-1 RAs and enhance their understanding of strategies which can improve patient access and adherence.
Before jumping into the activity content, reflect on your current knowledge of pharmacotherapies used to optimize joint health and surgical outcomes in those who are overweight or obese.
This module will focus on the clinical benefits of GLP-1 receptor agonists and GLP-1/ GIP receptor agonists and strategies for managing common adverse events.
This module will provide a thorough overview of the use of GLP-1 RAs to optimize joint health and surgical outcomes in patients who are overweight or obese.
This module focuses on patient-centered approaches for education and follow up regarding GLP-1 and GLP-1/GIP receptor agonists. Learn proven strategies for improving GLP-1 and GLP-1/GIP receptor agonist adherence and long-term outcomes.
Review what you have learned about obesity as it relates to orthopedic surgery and how pharmacotherapy can be used to optimize joint health and surgical outcomes. This short assessment reviews the program’s content and provides new information to enhance your clinical practice.
This Live Group Discussion will focus on a case of a 56-year-old male with a history of obesity, prediabetes, and osteoarthritis of the right hip. We will also address any questions you may have regarding the baseline and final assessments and the self-study modules.
Meet Emily, a 68-year-old female with a history of obesity, prediabetes, hypertension, and severe knee OA, planning for a knee replacement.
In light of the information reviewed and discussed during this program, please share an action plan that you will implement to improve the diagnosis and management for your patients with obesity/overweight who may require orthopedic surgery.
This Live Group Discussion will focus on a case of a 53-year-old female with a history of class III obesity, hypertension, dyslipidemia, and prediabetes. We will also review your submissions on the Patient Case Challenge and Action Plans.
